Ministry of Health says it can start vaccinating children in January, 'after listening to society'

Executive President said that immunizing can be launched in March this year

Kevin David/A7 Press/Estadão Content – Pfizer considers upgrading Covid-19 vaccine to new variant

The executive president of Pfizer, Albert Bourla, said this Monday, 10th, that a vaccine against covid-19 redesigned specifically aimed at Ômicron variant of Covid-19 will likely be needed, and that the lab may have one ready to roll out by March. Bourla said Pfizer and partner BioNTech are working on a version of the vaccine targeting Ômicron, as well as a vaccine that would include both the previous vaccine and one targeting the fast-spreading variant. “I think it’s the most likely scenario,” Bourla said at JP Morgan’s annual health conference, held virtually this year. “We are working on higher doses. We are working on different timelines. We are doing a lot of things right now as we speak.”

Bourla said Pfizer may be ready to seek regulatory approval from the U.S for a redesigned vaccine and launch it in March. According to Bourla, Pfizer has built up so much manufacturing capacity for the vaccine that it won’t be a problem to switch it right away. The vaccine against Covid-19 eventually it can be yearly for most people, Bourla said, and some high-risk groups may get the vaccines more often than that. Moderna Chief Executive Stéphane Bancel said last week that people may need another dose in the second half of the year as the effectiveness of the booster is likely to wane in the coming months.

*With information from Agência Brasil

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more